Company Biostage Inc Nasdaq
Equities
US41690A1060
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- USD | - |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Longevity Products
100.0
%
| - | - | 0 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Asia
100.0
%
| - | - | 0 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jun Li He
CEO | Chief Executive Officer | 49 | 31/08/21 |
David Green
CEO | Chief Executive Officer | 60 | 02/05/12 |
Hong Yu
PSD | President | 52 | 30/05/18 |
Director of Finance/CFO | 49 | 07/08/22 | |
Shun Fu Hu
COO | Chief Operating Officer | - | - |
William Fodor
CTO | Chief Tech/Sci/R&D Officer | 65 | 30/06/17 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Green
CEO | Chief Executive Officer | 60 | 02/05/12 |
Ronald Packard
BRD | Director/Board Member | 60 | 04/04/23 |
James Shmerling
BRD | Director/Board Member | 69 | 28/03/18 |
Ting Li
BRD | Director/Board Member | 47 | 06/11/18 |
Jun Li He
CEO | Chief Executive Officer | 49 | 31/08/21 |
Jason Jing Chen
BRD | Director/Board Member | 62 | 06/02/18 |
Herman Sanchez
BRD | Director/Board Member | 49 | 18/01/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 14,315,091 | 6,787,830 ( 47.42 %) | 0 | 47.42 % |
Company contact information
Harvard Apparatus Regenerative Technology, Inc.
84 October Hill Road Suite 11
01746, Holliston
+
http://www.biostage.comSector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+12.23% | 225B | |
+16.01% | 197B | |
+19.24% | 143B | |
+30.81% | 111B | |
+2.85% | 64.72B | |
+19.79% | 54.44B | |
+5.12% | 51.06B | |
+10.92% | 45.03B | |
+4.33% | 37.4B |
- Stock Market
- Equities
- HRGN Stock
- Stock
- Company Biostage Inc